Ionis Pharmaceuticals Inc (LTS:0JDI) Stock News, Headlines & Updates
Ionis Pharmaceuticals Inc Stock News from GuruFocus
- 1
Aug 07, 2024
Insider Sale at Ionis Pharmaceuticals Inc (IONS) by EVP, Chief Development Officer Richard Geary
GuruFocus Research • 9:34pm
Aug 02, 2024
Ionis Pharmaceuticals Inc (IONS) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advancements
GuruFocus Research • 1:13am
Q2 2024 Ionis Pharmaceuticals Inc Earnings Call Transcript
GuruFocus Research • 11:17pm
Aug 01, 2024
Ionis Pharmaceuticals Inc (IONS) Q2 2024 Earnings: EPS of -$0.45 Beats Estimates, Revenue Surpasses Expectations at $225 Million
GuruFocus Research • 10:31am
Ionis reports second quarter 2024 financial results
PRNewswire • 7:00am
Jul 22, 2024
Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome
PRNewswire • 7:00am
Jul 19, 2024
Ionis to hold second quarter 2024 financial results webcast
PRNewswire • 8:00am
Jul 18, 2024
Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease
PRNewswire • 7:00am
Jul 08, 2024
Ionis announces webcast to report HALOS study results for ION582 in Angelman syndrome
PRNewswire • 7:00am
Jun 25, 2024
Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
PRNewswire • 6:00am
Jun 18, 2024
Ionis announces expanded licensing agreement with Otsuka in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema
PRNewswire • 7:00am
Jun 17, 2024
Ionis to present at TD Cowen Genetic Medicines & RNA Summit
PRNewswire • 4:00pm
May 31, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news